InspireMD Inc (NYSEAMERICAN:NSPR) was the recipient of a significant increase in short interest in the month of September. As of September 14th, there was short interest totalling 587,153 shares, an increase of 52.9% from the August 31st total of 383,888 shares. Based on an average daily volume of 4,905,129 shares, the short-interest ratio is presently 0.1 days. Approximately 2.7% of the shares of the stock are short sold.

Shares of NSPR opened at $0.22 on Thursday. InspireMD has a 12 month low of $0.16 and a 12 month high of $20.30.

InspireMD (NYSEAMERICAN:NSPR) last announced its quarterly earnings results on Monday, August 6th. The medical equipment provider reported ($0.15) EPS for the quarter. The business had revenue of $1.00 million for the quarter. InspireMD had a negative return on equity of 720.33% and a negative net margin of 179.74%.

InspireMD Company Profile

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.

See Also: How to Invest in the Dividend Aristocrat Index

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.